☰ 🔍
🖊️Ask a Question
Electrical Engineering

What is true of docetaxel: A. It is used as a reserve drug for refractory breast and ovarian cancer B. It is a selective estrogen receptor modulator used for breast cancer C. It is effective only in estrogen receptor positive breast cancer D. Both 'B' and 'C' are correct

by 0 views
What is true of docetaxel:
A. It is used as a reserve drug for refractory
breast and ovarian cancer
B. It is a selective estrogen receptor modulator
used for breast cancer
C. It is effective only in estrogen receptor
positive breast cancer
D. Both 'B' and 'C' are correct
0 like 0 dislike

1 Answer

by
A. It is used as a reserve drug for refractory
breast and ovarian cancer
0 like 0 dislike

Related questions

by trupti chikram asked Jul 22, 2021 1 view
What is true of tamoxifen: A. It can induce endometrial proliferation in postmenopausal women B. It exerts antiestrogenic activity in bone C. It raises LDL-cholesterol levels D. It is ineffective in estrogen receptor-negative breast cancer

What is true of tamoxifen: A. It can induce endometrial proliferation in postmenopausal women B. It exerts antiestrogenic activity in bone C. It raises LDL-cholesterol levels D. It is ineffective in estrogen receptor-negative breast cancer
Answer : A. It can induce endometrial proliferation in postmenopausal women...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 22, 2021 0 views
Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol

Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol
Answer : . Ormeloxifen...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 22, 2021 0 views
Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate

Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate
Answer : B. Raloxifene...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 22, 2021 1 view
The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes

The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes
Answer : C. It has additional androgenic acitivity...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
The following is true of topiramate except: A. It is a broad spectrum antiepileptic drug B. It inhibits the enzyme carbonic anhydrase C. It is used as add-on therapy in refractory partial seizures D. It is not effective in generalized tonic-clonic seizures

The following is true of topiramate except: A. It is a broad spectrum antiepileptic drug B. It inhibits the enzyme carbonic anhydrase C. It is used as add-on therapy in refractory partial seizures D. It is not effective in generalized tonic-clonic seizures
Answer : D. It is not effective in generalized tonic-clonic seizures...

View solution
0 like 0 dislike
1 answer

50.5k questions

47.1k answers

240 comments

7.0k users

© 2025 Question Answer